Merck & Co. Newsletter
-
Merck & Co. Plans Elkton, Virginia, Manufacturing Operations
28 Oct 2025 15:21 GMT
Related Research
Multinational pharmaceutical company Merck & Co. plans to expand its operations in Elkton, Virginia. The $3 billion project is expected to create 500 jobs.
The investment will include the construction of a new 400,000-square-foot …
-
Lilly is set to lead pharma in 2026, but can it justify an $800B valuation?
01 Nov 2025 19:53 GMT
Eli Lilly is on track to overtake pharma rivals and claim the industry’s top spot by late 2026, completing one of the most dramatic repositionings in Big Pharma’s recent history. Aggressive and base scenarios place Lilly’s rise to the number one slot in …
-
DESTINY-Lung06 phase 3 trial of Enhertu initiated as first-line therapy in patients with HER2 overexpressing metastatic non-squamous NSCLC
01 Nov 2025 18:41 GMT
The first patient has been dosed in the DESTINYLung06 phase 3 trial Evaluating Enhertu (trastuzumab deruxtecan) plus pembrolizumab versus pembrolizumab, platinum-based chemotherapy and pemetrexed as a first-line treatment in patients with unresectable, …
-
LUNGevity Foundation Leads 2025 Lung Cancer Awareness Month to Drive Research, Awareness, and Early Detection
01 Nov 2025 19:37 GMT
Throughout November, LUNGevity is shining a light on the progress being made, and the work still ahead, to change the future of lung cancer
WASHINGTON, Nov. 1, 2025 /PRNewswire/ -- This November, LUNGevity Foundation is leading the nation's …
-
A legacy of loss: Family sues Merck, alleging plant toxins caused daughter’s cancer
28 Oct 2025 05:43 GMT
… loss: Family sues Merck, alleging plant toxins caused … a troubling history for Merck, notably the Vioxx scandal. In 2004 … the wake of the Vioxx fallout. Furthermore, environmental … brings multiple counts against Merck, including negligence, gross …
-
Companion Animal Health Market to Worth USD 61.74 Billion by 2034, Driven by Rising Pet Ownership and Humanization Trends
31 Oct 2025 14:00 GMT
Ottawa, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The global companion animal health market size was valued at USD 25.28 billion in 2024 and is predicted to hit around USD 61.74 billion by 2034, rising at a 9.34% CAGR, a study published by Towards Healthcare a …
-
Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer
31 Oct 2025 11:00 GMT
Phase 2 clinical trial underway with first patient dosed in October to support a clear path to Phase 3 based on previous alignment with FDA Patients randomized to either 10 or 20 mg/kg of muzastotug, in combination with KEYTRUDA with up to 30 patients …
-
Mastitis Market to Reach USD 2.52 Bn by 2032, Driven by AI Diagnostics, Antibiotic-Free Therapies & Vaccine Innovation
31 Oct 2025 09:27 GMT
Mastitis Market size was valued at USD 1.60 Bn. in 2024 and the is expected to grow at a CAGR of 5.8% from 2025 to 2032, reaching nearly USD 2.52 Bn. by 2032.
SAN FRANCISCO, CA, UNITED STATES, October 31, 2025 /EINPresswire.com/ -- Explore the …
-
Insulin Market Top Players, Segments & Regional Trends By 2034
31 Oct 2025 06:49 GMT
(MENAFN- Straits Research)
Introduction
Straits Research released its highly anticipated report,“ Global Insulin Market Size & Outlook, 2026-2034.” According to the study, the global market size is valued at USD 21.13 billion in 2025 and is projected …
-
COVID-19 in pregnancy may raise autism and neurodevelopmental disorder risk
31 Oct 2025 03:00 GMT
New research from Mass General Brigham reveals that COVID-19 infection in pregnancy may subtly alter fetal brain development, heightening the risk of speech, motor, and autism-related disorders in early childhood.
Study: Neurodevelopmental Outcomes of 3- …